(Q39019419)

8 September 2017

title

Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1. (English)

1 reference

8 September 2017

author name string

Deepa Kolaseri Krishnadas

1

1 reference

8 September 2017

Lei Bao

2

1 reference

8 September 2017

Fanqi Bai

3

1 reference

8 September 2017

Satheesh Cheeyancheri Chencheri

4

1 reference

8 September 2017

Kenneth Lucas

5

1 reference

8 September 2017

publication date

2 March 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

5753-5762

1 reference

Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Cellular immunotherapy for soft tissue sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Immune-based therapies for sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Immunomic analysis of human sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Wilms' tumor 1-specific cytotoxic T lymphocytes can be expanded from adult donors and cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Regulation by retinoic acid of ICAM-1 expression on human tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

CD4 cells can be more efficient at tumor rejection than CD8 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Prolonged Upregulation of the Expression of HLA Class I Antigens and Co stimulatory Molecules on Melanoma Cells Treated with 5-aza-2??-deoxycytidine (5-AZA-CdR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

Expression of cancer/testis (CT) antigens in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1764-9

LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.

21 January 2018

1 reference

12 December 2020

Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors

1 reference

12 December 2020

Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy.

1 reference

12 December 2020

Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells

1 reference

12 December 2020

High-throughput RT-PCR analysis of multiple transcripts using a microplate RNA isolation procedure.

1 reference

12 December 2020

Expression of cancer-testis (CT) antigens in placenta

1 reference

12 December 2020

Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.

1 reference

12 December 2020

Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis

1 reference

12 December 2020

Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.

1 reference

12 December 2020

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7

1 reference

12 December 2020

The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma.

1 reference

12 December 2020

The cancer/testis genes: review, standardization, and commentary.

1 reference

12 December 2020

Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.

1 reference

12 December 2020

Lymphocyte binding to K562 cells: effect of target cell irradiation and correlation with ICAM-1 and LFA-3 expression

1 reference

12 December 2020

Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3

1 reference

12 December 2020

10.1007/S13277-014-1764-9

Identifiers

DOI

1 reference

8 September 2017

1 reference